{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:06:44Z","timestamp":1778231204043,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:00:00Z","timestamp":1553731200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12933-019-0844-y","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T07:02:56Z","timestamp":1553756576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cardiovascular events, diabetes and guidelines: the virtue of simplicity"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2125-7924","authenticated-orcid":false,"given":"Ricardo J.","family":"Esper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto A.","family":"Nordaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,28]]},"reference":[{"key":"844_CR1","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nrcardio.2014.123","volume":"11","author":"O Alfieri","year":"2014","unstructured":"Alfieri O, Bongani M, Mayosi SJP, Sarrafzadegan N, Virmani R. Exploring unknowns in cardiology. Nat Rev Cardiol. 2014;11:664\u201370.","journal-title":"Nat Rev Cardiol"},{"key":"844_CR2","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1161\/01.CIR.89.5.2462","volume":"89","author":"HC Stary","year":"1994","unstructured":"Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis American Heart Association. Circulation. 1994;89:2462\u201378.","journal-title":"Circulation"},{"key":"844_CR3","unstructured":"Libby P, Folco EJ, Esper RJ. Inmunidad, inflamaci\u00f3n y ateroesclerosis. In: Esper RJ, Vilari\u00f1o JO (Eds): Progresos en Ateroesclerosis, Buenos Aires, Ediciones M\u00e9dicas del Sur, 2011, p. 23\u201347."},{"key":"844_CR4","unstructured":"Viles-Gonzalez JF, Fuster V, Esper RJ, Vilari\u00f1o JO, Badimon JJ: Enfermedad Aterotromb\u00f3tica. In: Esper RJ (Ed): Aterotrombosis en el tercer milenio. Barcelona, Prous Sciences, 2004, p. 1\u201322."},{"key":"844_CR5","first-page":"552","volume":"96","author":"RJ Esper","year":"2009","unstructured":"Esper RJ. Ateroesclerosis, una enfermedad inmuno-inflamatoria. Prensa Med Argent. 2009;96:552\u201370.","journal-title":"Prensa Med Argent"},{"key":"844_CR6","doi-asserted-by":"publisher","unstructured":"Esper RJ, Nordaby RA, Vilari\u00f1o JO, Paragano A, Cacharr\u00f3n JL, Machado RA. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol. 2006; 5: 4. \n                    https:\/\/doi.org\/10.1186\/1475-2843-5-4\n                    \n                  . \n                    http:\/\/www.cardiab.com\/content\/5\/1\/4\n                    \n                  .","DOI":"10.1186\/1475-2843-5-4"},{"key":"844_CR7","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","volume":"35","author":"PM Ridker","year":"2014","unstructured":"Ridker PM, L\u00fcscher TF. Anti-inflammatory therapies for cardiovascular diseases. Eur Heart J. 2014;35:1782\u201391.","journal-title":"Eur Heart J"},{"key":"844_CR8","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/eurheartj\/ehw207","volume":"37","author":"F Crea","year":"2016","unstructured":"Crea F, Liuzzo G. Anti-inflammatory treatment of acute coronary syndromes: the need for precision medicine. Eur Heart J. 2016;37:2414\u20136.","journal-title":"Eur Heart J"},{"key":"844_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nrrheum.2013.8","volume":"9","author":"EH Choy","year":"2013","unstructured":"Choy EH, Kavanaugh AF, Jones SA. The problem of choise current biologic agents and future prospects in RA. Nat Rheumatol. 2013;9:154\u201363.","journal-title":"Nat Rheumatol"},{"key":"844_CR10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/eurheartj\/ehs399","volume":"34","author":"G Liuzzo","year":"2013","unstructured":"Liuzzo G, Trotta F, Pedicino D. Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad and the unknow. Eur Heart J. 2013;34:556\u20139.","journal-title":"Eur Heart J"},{"key":"844_CR11","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/S0140-6736(16)31329-0","volume":"388","author":"MW Feinberg","year":"2016","unstructured":"Feinberg MW. No small task: therapeutic targeting of Lp(a) for cardiovascular disease. Lancet. 2016;388:2211\u20132.","journal-title":"Lancet"},{"key":"844_CR12","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1093\/eurheartj\/ehw576","volume":"37","author":"TF L\u00fcscher","year":"2016","unstructured":"L\u00fcscher TF. Frontiers in precision medicine: genes and their modulation by miRNAs. Eur Heart J. 2016;37:3247\u201350.","journal-title":"Eur Heart J"},{"key":"844_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5083\/ejcm.20424884.05","volume":"1","author":"AM El-Mowafy","year":"2009","unstructured":"El-Mowafy AM. Advances in averting cardiovascular anomalies to diabetes. J Cardiovasc Med. 2009;1:18\u201320. \n                    https:\/\/doi.org\/10.5083\/ejcm.20424884.05\n                    \n                  .","journal-title":"J Cardiovasc Med"},{"key":"844_CR14","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1016\/j.jacc.2018.10.031","volume":"72","author":"R Fern\u00e1ndez-Gimenez","year":"2018","unstructured":"Fern\u00e1ndez-Gimenez R, Al-Kazar M, Jaslow R, Carvajal I, Fuster V. Children present a window of opportunity for promoting health. J Am Col Cardiol. 2018;72:3310\u20139.","journal-title":"J Am Col Cardiol"},{"key":"844_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12933-018-0742-8","volume":"17","author":"D El-Lebedy","year":"2018","unstructured":"El-Lebedy D. Interaction between endothelial nitric oxide synthase rs1799983, cholesteryl ester-transfer protein rs708272 and angiopoietin-like protein 8 rs2278426 gene variants highly elevates the risk of type 2 diabetes mellitus and cardiovascular disease. Cardiovasc Diabetol. 2018;17:97. \n                    https:\/\/doi.org\/10.1186\/s12933-018-0742-8\n                    \n                  .","journal-title":"Cardiovasc Diabetol"},{"key":"844_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12933-018-0668-1","volume":"17","author":"GP Fandini","year":"2018","unstructured":"Fandini GP, Avogaro A. How to interpret the role of SDF-1\u03b1 on diabetic complications during therapy with DPP-4 inhibitors. Cardiovasc Diabetol. 2018;17:22. \n                    https:\/\/doi.org\/10.1186\/s12933-018-0668-1\n                    \n                  .","journal-title":"Cardiovasc Diabetol"},{"key":"844_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12872-018-0965-3","volume":"19","author":"NM Bogari","year":"2019","unstructured":"Bogari NM, Aljohani A, Amin AA, Al-Allaf FA, Dannoun A, Taher MM, et al. A genetic variant c.553G > T (rs2075291) in the apolipoprotein A5 gene is associated with altered triglycerides levels in coronary artery disease (CAD) patients with lipid lowering drug. BMC Cardiovasc Disorders. 2019;19:2. \n                    https:\/\/doi.org\/10.1186\/s12872-018-0965-3\n                    \n                  .","journal-title":"BMC Cardiovasc Disorders."},{"key":"844_CR18","unstructured":"Esper RJ, Antivero Esper P. Depresi\u00f3n, ataques de p\u00e1nico, estados de \u00e1nimo y eventos cardiovasculares. In: Esper RJ, Vilari\u00f1o JO (Eds): Prevenci\u00f3n Cardiovascular, Desaf\u00edos y Oportunidades. Buenos Aires, Intermedica, 2014, p: 205-218."},{"key":"844_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/cvr\/cvp165","volume":"83","author":"KR Sipido","year":"2009","unstructured":"Sipido KR, Tedgui A, Kristensen SD, Pasterkamp G, Schunkert H. Identifying needs and opportunities for advancing translational research in cardiovascular disease. Cardiovasc Res. 2009;83:425\u201335.","journal-title":"Cardiovasc Res"},{"key":"844_CR20","unstructured":"Indice de Mortalidad por Accidentes. Cumbre Anual del International Transport Forum (ITF) y Organizaci\u00f3n para la Cooperaci\u00f3n y el Desarrollo Econ\u00f3micos (OCDE). Buenos Aires, La Naci\u00f3n, Argentina, 29 de mayo de 2015."},{"key":"844_CR21","unstructured":"Fleitas Ortiz de Rosas, D. Homicidios a\u00f1os 2002-2012. Asociaci\u00f3n para pol\u00edticas p\u00fablicas. Buenos Aires, La Naci\u00f3n, Argentina, 15 de octubre 2014."},{"key":"844_CR22","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1093\/eurheartj\/ehw452","volume":"37","author":"TF L\u00fcscher","year":"2016","unstructured":"L\u00fcscher TF. Takotsubo. A japanese contribution to cardiology. Eur Heart J. 2016;37:2803\u20135.","journal-title":"Eur Heart J"},{"key":"844_CR23","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1161\/ATVBAHA.107.161240","volume":"28","author":"P Aukrust","year":"2008","unstructured":"Aukrust P, Halvorsen B, Yndestad A, Ueland T, \u00d8ie E, Otterdal K, et al. Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol. 2008;28:1900\u201319.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"844_CR24","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1056\/NEJMoa055373","volume":"355","author":"TJ Wang","year":"2006","unstructured":"Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631\u20139.","journal-title":"N Engl J Med"},{"key":"844_CR25","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1056\/NEJMp068249","volume":"355","author":"JH Ware","year":"2006","unstructured":"Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med. 2006;355:2615\u20137.","journal-title":"N Engl J Med"},{"key":"844_CR26","unstructured":"Badimon JJ, Garc\u00eda MJ. Diagn\u00f3stico de la aterosclerosis por im\u00e1genes. In: Esper RJ, Vilari\u00f1o JO (Eds): Progresos en Aterotrombosis. Buenos Aires, Ediciones M\u00e9dicas del Sur, 2011; p. 283\u201398."},{"key":"844_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1148\/radiol.2251010173","volume":"225","author":"AF Kopp","year":"2002","unstructured":"Kopp AF, Ohnesorge B, Becker C, Schr\u00f6der S, Heuschmid M, K\u00fcttner A, et al. Reproducibility and accuracy of coronary calcium measurements with multidetector row versus electron-beam CT. Radiology. 2002;225:113\u20139.","journal-title":"Radiology"},{"key":"844_CR28","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.jacc.2016.08.069","volume":"68","author":"A Arbab-Zadeh","year":"2016","unstructured":"Arbab-Zadeh A, Fuster V. The risk continuum of atherosclerosis and its implications for defining chd by coronary angiography. J Am Coll Cardiol. 2016;68:2467\u201378.","journal-title":"J Am Coll Cardiol"},{"key":"844_CR29","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1161\/CIR.0000000000000019","volume":"129","author":"KH Lichtman","year":"2014","unstructured":"Lichtman KH, Froelicher ES, Blumenthal JA, Carney RM, Dering LV, Frasure-Smith N, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations. A scientific statement from the American Heart Association. Circulation. 2014;129:1350\u201369.","journal-title":"Circulation"},{"key":"844_CR30","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/00006842-200111000-00009","volume":"63","author":"LD Kubzansky","year":"2001","unstructured":"Kubzansky LD, Sparrow LD, Vokonas P. Veterans affairs normative aging study minnesota multiphasic personality inventory bipolar revised optimism-pessimism scale. Psychosom Med. 2001;63:910\u20136.","journal-title":"Psychosom Med"},{"key":"844_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12933-018-0710-3","volume":"17","author":"G Cediel","year":"2018","unstructured":"Cediel G, Rueda F, Oxvig C, Oliveras T, Labata C, de Diego O, et al. Prognostic value of the Stanniocalcin-2\/PAPP-A\/IGFBP-4 axis in ST-segment elevation myocardial infarction. Cardiovasc Diabetol. 2018;17:63. \n                    https:\/\/doi.org\/10.1186\/s12933-018-0710-3\n                    \n                  .","journal-title":"Cardiovasc Diabetol."},{"key":"844_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12933-018-0729-5","volume":"17","author":"S Zhang","year":"2018","unstructured":"Zhang S, Dai J, Jia H, Hu S, Du H, Li N, et al. Non-culprit plaque characteristics in acute coronary syndrome patients with raised hemoglobinA1c: an intravascular optical coherence tomography study. Cardiovasc Diabetol. 2018;17:90. \n                    https:\/\/doi.org\/10.1186\/s12933-018-0729-5\n                    \n                  .","journal-title":"Cardiovasc Diabetol."},{"key":"844_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ijcard.2018.07.074","volume":"269","author":"N Kobayashi","year":"2018","unstructured":"Kobayashi N, Hata N, Tsaurumi M, Shibata Y, Okazaki H, Shirakabe A, Takano M, Seino Y, Shimizu W. Relation of coronary culprit morphology determined by optical coherence tomography and cardiac outcomes to preinfarction angina in patients with acute myocardial infarction. Int J Cardiol. 2018;269:365.","journal-title":"Int J Cardiol."},{"key":"844_CR34","unstructured":"Fuster V. Conferencia Inaugural 40 Congreso Argentino de Cardiolog\u00eda. Buenos Aires, 2014; Octubre 16."},{"key":"844_CR35","unstructured":"Esper RJ., Vilari\u00f1o JO. Riesgo Residual, Endotelio, Gen\u00e9tica y Tratamiento Personalizado. In: Esper RJ, Vilari\u00f1o JO (Eds): Progresos en Aterotrombosis. Buenos Aires, Ediciones M\u00e9dicas del Sur, 2011, p. 109\u2013126."},{"key":"844_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ahj.2008.08.010","volume":"157","author":"A Sachdeva","year":"2009","unstructured":"Sachdeva A, Cannon CP, Deedwania PC, LaBresh KA, Smith SC Jr, Dai D, et al. Lipid Levels in patients hospitalized with coronary artery disease: an analysis of 136.905 hospitalizations in Get with the Guidelines. Am Heart J. 2009;157:111\u20137.","journal-title":"Am Heart J"},{"key":"844_CR37","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/jama.290.7.898","volume":"290","author":"UN Khot","year":"2003","unstructured":"Khot UN, Khot MB, Bajzer CT, Sapp SK, Magnus Ohman E, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290:898\u2013904.","journal-title":"JAMA"},{"key":"844_CR38","unstructured":"Gotto AM, Moon J. Dislipidemias. In: Esper RJ, Vilari\u00f1o JO (Eds): Progresos en aterotrombosis. Buenos Aires, Ediciones M\u00e9dicas del Sur 2011, p. 79\u201396."},{"key":"844_CR39","unstructured":"L\u00fcscher TF. Manejo actual de los des\u00f3rdenes lip\u00eddicos. Enfoques entre las Gu\u00edas Europeas (ESC\/EAS) y americanas (ACC\/AHA). In: Esper RJ, Vilari\u00f1o JO (Eds): Prevenci\u00f3n Cardiovascular. Desaf\u00edos y Oportunidades. Buenos Aires, Intermedica, 2015, p. 53\u201362."},{"key":"844_CR40","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","volume":"375","author":"BA Ference","year":"2016","unstructured":"Ference BA, Robinson JG, Brook RD, Catapano AL, Chapman J, Neff DR, et al. Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N Engl J Med. 2016;375:2144\u201353.","journal-title":"N Engl J Med"},{"key":"844_CR41","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/eurheartj\/ehv043","volume":"36","author":"ES Stroes","year":"2015","unstructured":"Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel statement on assessment, aetiology, and management. Eur Heart J. 2015;36:1015\u201322.","journal-title":"Eur Heart J"},{"key":"844_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12933-018-0799-4","volume":"17","author":"K Kim","year":"2018","unstructured":"Kim K, Lee SH, Lee KY. Efect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea. Cardiovasc Diabetol. 2018;17:155. \n                    https:\/\/doi.org\/10.1186\/s12933-018-0799-4\n                    \n                  .","journal-title":"Cardiovasc Diabetol."},{"key":"844_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12933-018-0689-9","volume":"17","author":"SH Yang","year":"2018","unstructured":"Yang SH, Xia R, Cui CJ, Wang Y, Du Y, Chen ZG, et al. Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db\/db mice through a HNF-1a dependent mechanism. Cardiovasc Diabetol. 2018;17:48. \n                    https:\/\/doi.org\/10.1186\/s12933-018-0689-9\n                    \n                  .","journal-title":"Cardiovasc Diabetol."},{"key":"844_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/circresaha.118.314191","volume":"124","author":"TM Kaufman","year":"2019","unstructured":"Kaufman TM, Warden BA, Minnier J, Miles JR, Barton Duell P, Purnell JQ, et al. Application of PCSK9 inhibitors in practice. Part 2: the patient experience. Circ Res. 2019;124:32\u20137. \n                    https:\/\/doi.org\/10.1161\/circresaha.118.314191\n                    \n                  .","journal-title":"Circ Res."},{"key":"844_CR45","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1161\/CIRCOUTCOMES.111.000071","volume":"06","author":"H Naci","year":"2013","unstructured":"Naci H, Brugts J, Ades T. Comparative tolerability and harms of individual statins. A study-level network meta-analysis of 246 955 participants from 135 randomized controlled trials. Circ Cardiovasc Qual Outcomes. 2013;06:390\u20139.","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"844_CR46","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJMoa0801936","volume":"359","author":"Search Collaborative Group","year":"2008","unstructured":"Search Collaborative Group. SLCO1B1 variants and statin-induced myopathy-a genomic study. N Engl J Med. 2008;359:789\u201399.","journal-title":"N Engl J Med"},{"key":"844_CR47","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1093\/eurheartj\/ehv072","volume":"36","author":"D Preiss","year":"2015","unstructured":"Preiss D, Campbell RT, Murray HM, Ford I, Packard CJ, Sattard N, et al. The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished for the SEARCH Collaborative Group. SLCO1B1 data from major randomized trials. Eur Heart J. 2015;36:1536\u201346.","journal-title":"Eur Heart J"},{"key":"844_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrendo.2015.194","volume":"12","author":"EJ Betteridge","year":"2016","unstructured":"Betteridge EJ, Carmena R. The diabetogenic action of statins. Mechanisms and clinical implications. Nat Rew Endocrinol. 2016;12:99\u2013110.","journal-title":"Nat Rew Endocrinol."},{"key":"844_CR49","doi-asserted-by":"publisher","first-page":"39982","DOI":"10.1038\/srep39982","volume":"7","author":"S Wang","year":"2017","unstructured":"Wang S, Cai R, Yuan Y, Varghese Z, Moorhead J, Ruan XZ, et al. Association between reductions in low-density lipoprotein cholesterol wit statins therapy and the risk of new-onset diabetes: a meta-analysis. Sci Rep. 2017;7:39982. \n                    https:\/\/doi.org\/10.1038\/srep39982\n                    \n                  .","journal-title":"Sci Rep."},{"key":"844_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11886-018-0995-6","volume":"20","author":"A Agarwala","year":"2018","unstructured":"Agarwala A, Kulkarni S, Maddox T. The association of statin therapy with incident diabetes: evidence, mechanisms, and recommendation. Curr Cardiol Rep. 2018;20:50. \n                    https:\/\/doi.org\/10.1007\/s11886-018-0995-6\n                    \n                  .","journal-title":"Curr Cardiol Rep."},{"key":"844_CR51","first-page":"2","volume":"10","author":"M Laakso","year":"2017","unstructured":"Laakso M, Kuusisto J. Diabetes secondary to treatment with statins. Curr Dian Rep. 2017;10:2\u201310.","journal-title":"Curr Dian Rep"},{"key":"844_CR52","doi-asserted-by":"publisher","first-page":"e000438","DOI":"10.1136\/bmjdrc-2017-000438","volume":"5","author":"JP Crandall","year":"2017","unstructured":"Crandall JP, Mather K, Rajpathak SN, Goldberg RB, Watson K, Foo S, et al. Statin use and risk of developing diabetes: results from the Diabetes Prevention Program. BMJ Open Diab Res Care. 2017;5:e000438. \n                    https:\/\/doi.org\/10.1136\/bmjdrc-2017-000438\n                    \n                  .","journal-title":"BMJ Open Diab Res Care."},{"key":"844_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3528-5","author":"H Cederberg","year":"2017","unstructured":"Cederberg H, Stan\u010d\u00e1kov\u00e1 A, Yaluri N, Modi S, Kuusisto J, Laakso M. Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6\u00a0year follow-up study of the METSIM cohort. Diabetologia. 2017. \n                    https:\/\/doi.org\/10.1007\/s00125-015-3528-5\n                    \n                  .","journal-title":"Diabetologia."},{"key":"844_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30396-5","author":"AF Schmidt","year":"2017","unstructured":"Schmidt AF, Swerdlow DI, Holmes MV, Patel RS, Fairhurst-Hunter Z, Lyall DM, et al. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2017. \n                    https:\/\/doi.org\/10.1016\/S2213-8587(16)30396-5\n                    \n                  .","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"844_CR55","doi-asserted-by":"publisher","first-page":"e010401","DOI":"10.1136\/bmjopen-2015-010401","volume":"6","author":"U Ravnskov","year":"2016","unstructured":"Ravnskov U, Diamond DM, Hama R, Hamazaki T, Hammarskj\u00f6ld B, Hynes N, et al. Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ Open. 2016;6(6):e010401. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2015-010401\n                    \n                  .","journal-title":"BMJ Open."},{"key":"844_CR56","doi-asserted-by":"publisher","first-page":"c2197","DOI":"10.1136\/bmj.c2197","volume":"340","author":"J Hippisley-Cox","year":"2010","unstructured":"Hippisley-Cox J, Coupland C. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ. 2010;340:c2197.","journal-title":"BMJ"},{"issue":"1","key":"844_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jamacardio.2016.4052","volume":"2","author":"F Rodriguez","year":"2017","unstructured":"Rodriguez F, Maron DJ, Knowles JW, Viraniy SS, Lin S, Heidenreich PA. Association between intensity of statin therapy and mortality in patients with atherosclerotic cardiovascular disease. JAMA Cardiol. 2017;2(1):47\u201354.","journal-title":"JAMA Cardiol"},{"key":"844_CR58","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.2337\/db14-0020","volume":"63","author":"JB Halter","year":"2014","unstructured":"Halter JB, Musi N, McFarland Horne F, Crandall JP, Goldberg A, Harkless L, et al. Diabetes and cardiovascular disease in older adults: current status and future directions. Diabetes. 2014;63:2578\u201389.","journal-title":"Diabetes"},{"key":"844_CR59","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1056\/NEJMp1203020","volume":"366","author":"A Goldfine","year":"2012","unstructured":"Goldfine A. Is it really time to reassess benefits and risks? N Engl J Med. 2012;366:1752\u20135.","journal-title":"N Engl J Med"},{"key":"844_CR60","first-page":"606","volume":"84","author":"RA Borracci","year":"2016","unstructured":"Borracci RA. Fallibility of the ethics committees in medical research. Rev Argent Cardiol. 2016;84:606\u20139.","journal-title":"Rev Argent Cardiol"},{"key":"844_CR61","doi-asserted-by":"publisher","first-page":"361","DOI":"10.7775\/rac.v86.i5.13767","volume":"86","author":"H Doval","year":"2018","unstructured":"Doval H. Changing the paradigm of primary care: behavioral interventions, subsidies and taxes to \u201cchange lifestyle\u201d. Rev Argent Cardiol. 2018;86:361\u20135.","journal-title":"Rev Argent Cardiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0844-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-019-0844-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0844-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:16:02Z","timestamp":1585268162000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-019-0844-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,28]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["844"],"URL":"https:\/\/doi.org\/10.1186\/s12933-019-0844-y","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,28]]},"assertion":[{"value":"11 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"42"}}